Psoriasis: Treatment of patients with limited disease

Because at least 80% of patients with psoriasis have limited disease, it is important to address the clinical approach to the treatment of these patients using the published AAD guidelines. We will also address several important clinical scenarios that require special attention, including inverse/intertriginous psoriasis, genital psoriasis, scalp psoriasis, and the treatment of women of childbearing potential. Although no example is given in the cases below, it is important to assess all patients, even those with limited psoriasis, for the presence of PsA. This assessment should always include questions regarding the onset of joint symptoms, particularly the presence of morning stiffness lasting a minimum of 30 minutes, with appropriate examination for tender, swollen, or deformed joints. The presence of PsA indicates a need for more active intervention rather than purely topical therapies or UV-based therapies. 


View case 1: Limited disease

Navigate section 6 of the psoriasis guideline: Case-based review

Citation note

Menter A, Korman NJ, Elmets CA,Feldman SR, Gelfand JM, Gordon KB, Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011 Jul;65(1):137-74. 



View the AAD guidelines disclaimer.